Skip to main content

Beeler Brian K's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Aug 17, 2021

Accession no.
0001209191-21-051912
Filed
Aug 17, 2021
Trade date
Aug 16, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.94M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Beeler Brian KCIK 0001641580Officer (EVP, General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2021Ordinary SharesMOption exerciseAcquired+65,857$22.14+$1,458,073.98165,816Direct
Aug 16, 2021Ordinary SharesSSaleDisposed−74,898$106.00−$7,939,18890,918Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 16, 2021Ordinary SharesMOption exerciseDisposed−65,857$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)